18 June 2013
Keywords: bi, gsk, co-package, hiv, drugs, germany, boehringer
Article | 19 July 2004
Germany's Boehringer Ingelheim and UK drug major GlaxoSmithKline havesigned a letter of intent for an accelerated development program for a
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
19 July 2004
26 July 2004
© 2013 thepharmaletter.com